Carl Zeiss Meditec (0DHC) Ownership - Who Owns Carl Zeiss Meditec?
18 Followers
Carl Zeiss Meditec (0DHC) Ownership Overview
- 1.80% Mutual Funds
- 0.01% Other Institutional Investors
- 3.12% ETFs
- 95.07% Public Companies and Individual Investors
The ownership structure of Carl Zeiss Meditec (GB:0DHC) stock is a mix of institutional, retail, and individual investors. Approximately 4.93% of the company’s stock is owned by Institutional Investors, and 95.07% is owned by Public Companies and Individual Investors.
The ownership structure of Carl Zeiss Meditec (GB:0DHC) stock is a mix of institutional, retail, and individual investors. Approximately 4.93% of the company’s stock is owned by Institutional Investors, and 95.07% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Sep 09, 2026 | Andreas Pecher | €20,238 | |
| Sep 03, 2026 | Justus Felix Wehmer | €103,568 | |
| May 27, 2026 | Peter Kameritsch | €51,800 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 1,127,902 | Institution | 1.26% | 44,272,409 |
| Ishares | 908,557 | Institution | 1.02% | 35,662,679 |
| Vanguard Star Funds | 510,318 | Institution | 0.57% | 20,031,002 |
| Vanguard Tax-managed Funds | 346,676 | Institution | 0.39% | 13,607,726 |
| Vanguard International Equity Index Funds | 246,335 | Institution | 0.28% | 9,669,141 |
| Dimensional | 165,859 | Institution | 0.19% | 6,510,297 |
| Investment Managers Series Trust | 135,000 | Institution | 0.15% | 5,299,020 |
| Schwab | 128,674 | Institution | 0.14% | 5,050,712 |
| Amundi | 115,625 | Institution | 0.13% | 4,538,513 |
| Putnam Investment Funds | 114,530 | Institution | 0.13% | 4,495,532 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Star Funds | 510,318 | Institution | 0.57% | 20,031,002 |
| Vanguard Tax-managed Funds | 346,676 | Institution | 0.39% | 13,607,726 |
| Vanguard International Equity Index Funds | 246,335 | Institution | 0.28% | 9,669,141 |
| Investment Managers Series Trust | 135,000 | Institution | 0.15% | 5,299,020 |
| Putnam Investment Funds | 114,530 | Institution | 0.13% | 4,495,532 |
| Dfa Investment Dimensions Group Inc | 94,015 | Institution | 0.11% | 3,690,277 |
| Morningstar Funds Trust | 93,585 | Institution | 0.10% | 3,673,398 |
| Tiaa-cref Funds | 58,838 | Institution | 0.07% | 2,309,509 |
| Lazard Funds Inc | 38,393 | Institution | 0.04% | 1,507,002 |
| Fidelity Salem Street Trust | 22,121 | Institution | 0.02% | 868,293 |
FAQ
What percentage of Carl Zeiss Meditec (GB:0DHC) stock is held by institutional investors?
According to the latest TipRanks data, approximately 4.93% of Carl Zeiss Meditec (GB:0DHC) stock is held by institutional investors: 1.80% by mutual funds, 3.12% by ETFs and 0.01% by other institutional investors.
What percentage of Carl Zeiss Meditec (GB:0DHC) stock is held by retail investors?
According to the latest TipRanks data, approximately 95.07% of Carl Zeiss Meditec (GB:0DHC) stock is held by public companies and individual investors.
Who owns the most shares of Carl Zeiss Meditec (GB:0DHC)?
Vanguard owns the most shares of Carl Zeiss Meditec (GB:0DHC).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
